Hippo (NYSE:HIPO) Price Target Raised to $26.00

Hippo (NYSE:HIPO - Get Free Report) had its target price increased by stock analysts at Keefe, Bruyette & Woods from $24.00 to $26.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a "market perform" rating on the stock. Keefe, Bruyette & Woods' price target suggests a potential upside of 7.44% from the company's current price.

Separately, Jefferies Financial Group dropped their target price on Hippo from $43.00 to $30.00 and set a "buy" rating on the stock in a research report on Friday, April 11th.

Hippo Trading Down 1.4 %

Shares of HIPO stock traded down $0.35 on Tuesday, hitting $24.20. The stock had a trading volume of 99,538 shares, compared to its average volume of 165,829. Hippo has a twelve month low of $14.58 and a twelve month high of $35.44. The company has a fifty day moving average price of $25.96 and a two-hundred day moving average price of $26.24. The firm has a market cap of $606.98 million, a P/E ratio of -4.64 and a beta of 1.49.

Hippo (NYSE:HIPO - Get Free Report) last posted its earnings results on Wednesday, March 5th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.15) by $0.08. Hippo had a negative return on equity of 36.38% and a negative net margin of 37.94%. The firm had revenue of $102.00 million during the quarter, compared to analysts' expectations of $97.83 million. On average, analysts expect that Hippo will post -3.63 earnings per share for the current year.

Insider Transactions at Hippo

In related news, CEO Torben Ostergaard sold 21,146 shares of the stock in a transaction that occurred on Tuesday, February 4th. The shares were sold at an average price of $30.05, for a total transaction of $635,437.30. Following the sale, the chief executive officer now owns 74,120 shares in the company, valued at approximately $2,227,306. This trade represents a 22.20 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Chairman Assaf Wand sold 12,250 shares of Hippo stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $26.76, for a total value of $327,810.00. Following the completion of the transaction, the chairman now owns 499,064 shares in the company, valued at approximately $13,354,952.64. The trade was a 2.40 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,997 shares of company stock worth $1,469,538. Company insiders own 11.37% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. BNP Paribas Financial Markets bought a new stake in shares of Hippo during the 4th quarter valued at approximately $118,000. The Manufacturers Life Insurance Company bought a new stake in shares of Hippo during the fourth quarter worth $200,000. Two Sigma Advisers LP acquired a new position in shares of Hippo during the fourth quarter worth $200,000. EntryPoint Capital LLC bought a new position in shares of Hippo in the 4th quarter valued at $204,000. Finally, GAMMA Investing LLC boosted its holdings in shares of Hippo by 4,916.3% during the 1st quarter. GAMMA Investing LLC now owns 8,026 shares of the company's stock valued at $2,050,000 after acquiring an additional 7,866 shares in the last quarter. Institutional investors and hedge funds own 43.01% of the company's stock.

Hippo Company Profile

Hippo Holdings Inc provides property and casualty insurance products to individuals and business customers primarily in the United States. The company operates through three segments: Services, Insurance-as-a-Service, and Hippo Home Insurance Program. Its insurance products include homeowners' insurance against risks of fire, wind, and theft, as well as other personal lines policies from third party carriers; and personal and commercial, as well as home, auto, cyber, small business, life, specialty lines, and other insurance products.